193 related articles for article (PubMed ID: 32212938)
1.
Goto D; Komeda K; Uwatoko N; Nakashima M; Koike M; Kawai K; Kodama Y; Miyazawa A; Tanaka I; Hase T; Morise M; Hasegawa Y; Kawabe T; Sato M
Cancer Invest; 2020 Apr; 38(4):240-249. PubMed ID: 32212938
[TBL] [Abstract][Full Text] [Related]
2. UHRF1 predicts poor prognosis by triggering cell cycle in lung adenocarcinoma.
Tu Z; Deng X; Hou S; Feng A; Zhang Q
J Cell Mol Med; 2020 Jul; 24(14):8069-8077. PubMed ID: 32495469
[TBL] [Abstract][Full Text] [Related]
3. CDK1 serves as a potential prognostic biomarker and target for lung cancer.
Li M; He F; Zhang Z; Xiang Z; Hu D
J Int Med Res; 2020 Feb; 48(2):300060519897508. PubMed ID: 32020821
[TBL] [Abstract][Full Text] [Related]
4. UHRF1 regulates global DNA hypomethylation and is associated with poor prognosis in esophageal squamous cell carcinoma.
Nakamura K; Baba Y; Kosumi K; Harada K; Shigaki H; Miyake K; Kiyozumi Y; Ohuchi M; Kurashige J; Ishimoto T; Iwatsuki M; Sakamoto Y; Yoshida N; Watanabe M; Nakao M; Baba H
Oncotarget; 2016 Sep; 7(36):57821-57831. PubMed ID: 27507047
[TBL] [Abstract][Full Text] [Related]
5. Differential
Lin S; Tian C; Li J; Liu B; Ma T; Chen K; Gong W; Wang JM; Huang J
Oncol Rep; 2021 May; 45(5):. PubMed ID: 33786615
[TBL] [Abstract][Full Text] [Related]
6. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma.
Xu XL; Gong Y; Zhao DP
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913
[TBL] [Abstract][Full Text] [Related]
7. UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma.
Kostyrko K; Román M; Lee AG; Simpson DR; Dinh PT; Leung SG; Marini KD; Kelly MR; Broyde J; Califano A; Jackson PK; Sweet-Cordero EA
Nat Commun; 2023 Jul; 14(1):3966. PubMed ID: 37407562
[TBL] [Abstract][Full Text] [Related]
8. MiR-9-1 Suppresses Cell Proliferation and Promotes Apoptosis by Targeting UHRF1 in Lung Cancer.
Jia CY; Xiang W; Liu JB; Jiang GX; Sun F; Wu JJ; Yang XL; Xin R; Shi Y; Zhang DD; Li W; Zuberi Z; Zhang J; Lu GX; Wang HM; Wang PY; Yu F; Lv ZW; Ma YS; Fu D
Technol Cancer Res Treat; 2021; 20():15330338211041191. PubMed ID: 34520284
[TBL] [Abstract][Full Text] [Related]
9. UHRF1 Induces Methylation of the
Kim MJ; Lee HJ; Choi MY; Kang SS; Kim YS; Shin JK; Choi WS
Mol Cells; 2021 Mar; 44(3):146-159. PubMed ID: 33795533
[TBL] [Abstract][Full Text] [Related]
10. UHRF1 is a novel diagnostic marker of lung cancer.
Unoki M; Daigo Y; Koinuma J; Tsuchiya E; Hamamoto R; Nakamura Y
Br J Cancer; 2010 Jul; 103(2):217-22. PubMed ID: 20517312
[TBL] [Abstract][Full Text] [Related]
11. UHRF1 plays an oncogenic role in small cell lung cancer.
Hou J; Li W; Zhang S; Tan D; Lv K; Zhu Y; Hou Y; Guo H; Jiang L
Mol Carcinog; 2023 Mar; 62(3):385-397. PubMed ID: 36537722
[TBL] [Abstract][Full Text] [Related]
12. UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer.
Daskalos A; Oleksiewicz U; Filia A; Nikolaidis G; Xinarianos G; Gosney JR; Malliri A; Field JK; Liloglou T
Cancer; 2011 Mar; 117(5):1027-37. PubMed ID: 21351083
[TBL] [Abstract][Full Text] [Related]
13. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma.
Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X
Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686
[TBL] [Abstract][Full Text] [Related]
14. UHRF1 is regulated by miR-124-3p and promotes cell proliferation in intrahepatic cholangiocarcinoma.
Zhu M; Wei C; Lin J; Dong S; Gao D; Chen J; Zhao Y; Liu B
J Cell Physiol; 2019 Nov; 234(11):19875-19885. PubMed ID: 30989656
[TBL] [Abstract][Full Text] [Related]
15. Elevated UHRF1 expression contributes to poor prognosis by promoting cell proliferation and metastasis in hepatocellular carcinoma.
Liu X; Ou H; Xiang L; Li X; Huang Y; Yang D
Oncotarget; 2017 Feb; 8(6):10510-10522. PubMed ID: 28060737
[TBL] [Abstract][Full Text] [Related]
16. UHRF1 overexpression is involved in cell proliferation and biochemical recurrence in prostate cancer after radical prostatectomy.
Wan X; Yang S; Huang W; Wu D; Chen H; Wu M; Li J; Li T; Li Y
J Exp Clin Cancer Res; 2016 Feb; 35():34. PubMed ID: 26884069
[TBL] [Abstract][Full Text] [Related]
17. The bioinformatics analysis of RIOX2 gene in lung adenocarcinoma and squamous cell carcinoma.
Sun B; Zhao H
PLoS One; 2021; 16(12):e0259447. PubMed ID: 34855761
[TBL] [Abstract][Full Text] [Related]
18. UHRF1 depletion and HDAC inhibition reactivate epigenetically silenced genes in colorectal cancer cells.
Niinuma T; Kitajima H; Kai M; Yamamoto E; Yorozu A; Ishiguro K; Sasaki H; Sudo G; Toyota M; Hatahira T; Maruyama R; Tokino T; Nakase H; Sugai T; Suzuki H
Clin Epigenetics; 2019 May; 11(1):70. PubMed ID: 31064417
[TBL] [Abstract][Full Text] [Related]
19. WDR79 mediates the proliferation of non-small cell lung cancer cells by regulating the stability of UHRF1.
Chen J; Sheng X; Ma H; Tang Z; Yang C; Cao L; Sun Y; Deng T; Feng P; Hu B; Wei D; Liu J; Xiong W; Ye M
J Cell Mol Med; 2018 May; 22(5):2856-2864. PubMed ID: 29516630
[TBL] [Abstract][Full Text] [Related]
20. UHRF1 Knockdown Attenuates Cell Growth, Migration, and Invasion in Cutaneous Squamous Cell Carcinoma.
Li Q; Chu Z; Geng S
Cancer Invest; 2021 Jan; 39(1):84-97. PubMed ID: 33058714
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
